# UNIVERSAL DISPLAY CORP \PA\ (OLED)

Informational only - not investment advice.

CIK: 0001005284
SIC: 3670 Electronic Components & Accessories
SIC breadcrumb: [Manufacturing](/division/D/) > [Electronic And Other Electrical Equipment And Components, Except Computer Equipment](/major-group/36/) > [SIC 3670 Electronic Components & Accessories](/industry/3670/)
Latest 10-K filed: 2026-02-19
SEC page: https://www.sec.gov/edgar/browse/?CIK=1005284
Filing source: https://www.sec.gov/Archives/edgar/data/1005284/000119312526059371/oled-20251231.htm

## At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-19 · accession 0001193125-26-059371 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001005284.json

| Metric | Value | FY | Provenance |
| --- | ---: | ---: | --- |
| Revenue | 650,611,000 USD | 2025 | verified |
| Net income | 242,075,000 USD | 2025 | verified |
| Assets | 1,963,762,000 USD | 2025 | verified |
| Free cash flow | 154,360,000 USD | 2025 | computed |
| Net margin | 37.21% | 2025 | computed |
| Operating margin | 38.21% | 2025 | computed |
| Revenue YoY | +0.45% | 2025 | computed |
| ROE | 13.75% | 2025 | computed |

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

### Peer percentile fingerprint

| Ratio | OLED | Peer median | Percentile | N |
| --- | ---: | ---: | ---: | ---: |
| Net margin | 37.2% | 4.4% | 97 | 135 |
| Operating margin | 38.2% | 4.4% | 98 | 128 |
| Revenue growth | 0.5% | 10.2% | 23 | 142 |
| FCF margin | 23.7% | 8.0% | 88 | 138 |
| ROE | 13.7% | 5.4% | 67 | 136 |
| ROA | 12.3% | 2.7% | 83 | 143 |
| Liabilities / equity | 0.12 | 0.81 | 5 | 138 |
| Current ratio | 10.06 | 2.59 | 94 | 144 |

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 36 Electronic And Other Electrical Equipment And Components, Except Computer Equipment, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

## Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
| --- | ---: | --- | ---: | --- |
| Revenue | 650611000 | USD | 2025 | 2026-02-19 |
| Net income | 242075000 | USD | 2025 | 2026-02-19 |
| Assets | 1963762000 | USD | 2025 | 2026-02-19 |

## Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-19. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001005284.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

| Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue |  |  |  | 198,886,000 | 335,629,000 | 247,414,000 | 405,177,000 | 428,867,000 | 553,525,000 | 616,619,000 | 576,429,000 | 647,684,000 | 650,611,000 |
| Net income |  |  |  | 48,070,000 | 103,885,000 | 58,840,000 | 138,304,000 | 133,372,000 | 184,213,000 | 210,061,000 | 203,011,000 | 222,079,000 | 242,075,000 |
| Operating income |  |  |  | 68,413,000 | 146,247,000 | 56,735,000 | 158,343,000 | 157,526,000 | 227,644,000 | 267,110,000 | 217,189,000 | 238,803,000 | 248,578,000 |
| Gross profit |  |  |  | 172,598,000 | 280,931,000 | 193,873,000 | 329,803,000 | 343,389,000 | 438,534,000 | 488,723,000 | 441,053,000 | 499,223,000 | 496,485,000 |
| Diluted EPS |  |  |  | 1.02 | 2.18 | 1.24 | 2.92 | 2.80 | 3.87 | 4.40 | 4.24 | 4.65 | 5.08 |
| Operating cash flow |  |  |  | 80,338,000 | 133,365,000 | 121,796,000 | 193,912,000 | 148,792,000 | 191,105,000 | 126,815,000 | 154,777,000 | 253,740,000 | 210,830,000 |
| Capital expenditures |  |  |  | 7,300,000 | 29,803,000 | 25,391,000 | 30,059,000 | 27,991,000 | 43,161,000 | 42,497,000 | 59,792,000 | 42,637,000 | 56,470,000 |
| Dividends paid |  |  |  |  | 5,652,000 | 11,314,000 | 18,853,000 | 28,445,000 | 37,931,000 | 56,996,000 | 66,735,000 | 76,169,000 | 85,549,000 |
| Share buybacks | 5,456,000 | 29,500,000 | 0.00 |  |  | 477,000 | 649,000 | 0.00 | 0.00 |  | 0.00 | 0.00 | 32,881,000 |
| Assets |  |  |  | 627,559,000 | 779,956,000 | 933,424,000 | 1,120,157,000 | 1,269,228,000 | 1,466,919,000 | 1,532,820,000 | 1,668,961,000 | 1,832,333,000 | 1,963,762,000 |
| Liabilities |  |  |  | 99,091,000 | 120,902,000 | 242,918,000 | 308,708,000 | 356,514,000 | 367,005,000 | 257,451,000 | 221,735,000 | 215,808,000 | 202,743,000 |
| Stockholders' equity |  |  |  | 528,468,000 | 659,054,000 | 690,506,000 | 811,449,000 | 912,714,000 | 1,099,914,000 | 1,275,369,000 | 1,447,226,000 | 1,616,525,000 | 1,761,019,000 |
| Cash and cash equivalents |  |  |  | 139,365,000 | 132,840,000 | 211,022,000 | 131,627,000 | 630,012,000 | 311,993,000 | 93,430,000 | 91,985,000 | 98,980,000 | 138,353,000 |
| Free cash flow |  |  |  | 73,038,000 | 103,562,000 | 96,405,000 | 163,853,000 | 120,801,000 | 147,944,000 | 84,318,000 | 94,985,000 | 211,103,000 | 154,360,000 |

### Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

| Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net margin |  |  |  | 24.17% | 30.95% | 23.78% | 34.13% | 31.10% | 33.28% | 34.07% | 35.22% | 34.29% | 37.21% |
| Operating margin |  |  |  | 34.40% | 43.57% | 22.93% | 39.08% | 36.73% | 41.13% | 43.32% | 37.68% | 36.87% | 38.21% |
| Return on equity |  |  |  | 9.10% | 15.76% | 8.52% | 17.04% | 14.61% | 16.75% | 16.47% | 14.03% | 13.74% | 13.75% |
| Return on assets |  |  |  | 7.66% | 13.32% | 6.30% | 12.35% | 10.51% | 12.56% | 13.70% | 12.16% | 12.12% | 12.33% |
| Liabilities / equity |  |  |  | 0.19 | 0.18 | 0.35 | 0.38 | 0.39 | 0.33 | 0.20 | 0.15 | 0.13 | 0.12 |
| Current ratio |  |  |  | 9.58 | 8.13 | 4.77 | 4.91 | 5.61 | 4.93 | 6.63 | 7.72 | 7.18 | 10.06 |

## As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.


## Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-07-30. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001005284.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

| Quarter | End date | Revenue | Net income | Diluted EPS | Method |
| --- | --- | ---: | ---: | ---: | --- |
| 2022-Q3 | 2022-09-30 |  |  | 1.12 | reported discrete quarter |
| 2023-Q1 | 2023-03-31 |  |  | 0.83 | reported discrete quarter |
| 2023-Q2 | 2023-06-30 |  |  | 1.04 | reported discrete quarter |
| 2023-Q3 | 2023-09-30 | 141,077,000 | 51,516,000 | 1.08 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 158,320,000 | 61,978,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2024-Q1 | 2024-03-31 | 165,259,000 | 56,853,000 | 1.19 | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 158,505,000 | 52,337,000 | 1.10 | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 161,627,000 | 66,870,000 | 1.40 | reported discrete quarter |
| 2024-Q4 | 2024-12-31 | 162,293,000 | 46,019,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2025-Q1 | 2025-03-31 | 166,277,000 | 64,444,000 | 1.35 | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 171,794,000 | 67,264,000 | 1.41 | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 139,613,000 | 44,025,000 | 0.92 | reported discrete quarter |
| 2025-Q4 | 2025-12-31 | 172,927,000 | 66,342,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2026-Q1 | 2026-03-31 | 142,211,000 | 35,896,000 | 0.76 | reported discrete quarter |
| 2026-Q2 | 2026-06-30 | 152,157,000 | 49,421,000 | 1.06 | reported discrete quarter |

## Filed narrative (10-K & 10-Q)

## Business

Verbatim Item 1 Business section from OLED's latest 10-K: [/company/OLED/business/](/company/OLED/business/).

## Risk Factors

Verbatim Item 1A Risk Factors from OLED's latest 10-K: [/company/OLED/risk-factors/](/company/OLED/risk-factors/).

## Latest quarter (10-Q)

Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1005284/000119312526326123/oled-20260630.htm

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary.
Confidence: high
Filing date: 2026-07-30
Report date: 2026-06-30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited Consolidated Financial Statements and related notes above.

CAUTIONARY STATEMENT

CONCERNING FORWARD-LOOKING STATEMENTS

This discussion and analysis contains some “forward-looking statements.” Forward-looking statements concern possible or assumed future results of operations, including descriptions of our business strategies and customer relationships. These statements often include words such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate,” “seek,” “will,” “may” or similar expressions. These statements are based on assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors that we believe are appropriate in these circumstances.

As you read and consider this discussion and analysis, you should not place undue reliance on any forward-looking statements. You should understand that these statements involve substantial risk and uncertainty and are not guarantees of future performance or results. They depend on many factors that are discussed further in the sections entitled (Risk Factors) in our Annual Report on Form 10-K for the year ended December 31, 2025, as supplemented by disclosures in Item 1A of Part II below. Changes or developments in any of these areas could affect our financial results or results of operations and could cause actual results to differ materially from those contemplated in the forward-looking statements.

All forward-looking statements speak only as of the date of this report or the documents incorporated by reference, as the case may be. We do not undertake any duty to update any of these forward-looking statements to reflect events or circumstances after the date of this report or to reflect the occurrence of unanticipated events.

OVERVIEW

We are a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display applications, such as mobile phones, televisions, monitors, wearables, tablets, portable media devices, notebook computers, personal computers, automotive applications and specialty lighting products. Since 1994, we have been engaged and expect to continue to be primarily engaged, in funding and performing research and development activities relating to OLED technologies and materials, and commercializing these technologies and materials. We derive our revenue primarily from the following:

•
sales of OLED materials for evaluation, development and commercial manufacturing;

•
intellectual property and technology licensing;

•
technology development and support, including third-party collaboration efforts and providing support to third parties for commercialization of their OLED products; and

•
contract research services in the areas of chemical materials synthesis research, development and commercialization for non-OLED applications.

Material sales relate to our sale of OLED materials for incorporation into our customers’ commercial OLED products or for their OLED development and evaluation activities. Material sales are generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties.

We receive license and royalty payments under certain commercial, development and technology evaluation agreements, some of which are non-refundable advances. These payments may include royalty and license fees made pursuant to license agreements and also license fees included as part of certain commercial supply agreements. These payments are included in the estimate of total contract consideration by customer and recognized as revenue over the contract term based on material units sold at the estimated per unit fee over the life of the contract.

On December 2, 2022, we entered into a commercial patent license agreement with Samsung Display Co., Ltd. (SDC), replacing a previous license agreement that had been in place since 2018. This agreement, which covers the manufacture and sale of specified OLED display materials, was effective as of January 1, 2023 and lasts through the end of 2027 with an additional two-year extension option for SDC. Under this agreement, we are being paid a license fee, which includes quarterly and annual payments over the agreement term. The agreement conveys to SDC the non-exclusive right to use certain of our intellectual property assets for a limited period of time that is less than the estimated life of the assets.

29

At the same time that we entered into the current commercial license agreement with SDC, we also entered into a material purchase agreement with SDC, which lasts for the same term as the license agreement and is subject to the same extension option. This new material purchase agreement replaced a previous purchase agreement that had been in place since 2018. Under the material purchase agreement, SDC agrees to purchase from us a minimum amount of red and green phosphorescent emitter materials for use in the manufacture of licensed products. This minimum commitment is subject to SDC’s requirements for phosphorescent emitter materials and our ability to meet these requirements over the term of the supplemental agreement.

In 2015, we entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display). In 2026, we and LG Display entered into new agreements that extended the terms of these agreements at least through the end of 2030. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under their patent portfolio. The patent license calls for minimum annual license fees and additional incremental license fees based on LG Display’s volume of sale of licensed products. The OLED commercial supply agreement provides for the sale of dopant and host materials for use by LG Display.

In 2023, we entered into new long-term, multi-year agreements with BOE Technology Group Co., Ltd. (BOE). Under these agreements, we have granted BOE non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. We also supply phosphorescent OLED materials to BOE for use in its licensed products.

In 2019, we entered into an evaluation and commercial supply relationship with Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT). In 2020, we entered into long-term, multi-year agreements with CSOT. Under these agreements, we have granted CSOT non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. We also supply phosphorescent OLED materials to CSOT for use in its licensed products.

In 2024, we entered into new long-term, multi-year agreements with Visionox Technology, Inc. (Visionox). Under these agreements, we have granted Visionox non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. Additionally, we supply phosphorescent OLED materials to Visionox for use in its licensed products.

In 2025, we entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma Microelectronics Co., Ltd. (Tianma). Under the agreements, we have granted Tianma non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. Additionally, we supply phosphorescent OLED materials to Tianma for use in its licensed products.

In 2016, we acquired Adesis, Inc. (Adesis) which has operations in New Castle and Wilmington, Delaware. Adesis is a contract development and manufacturing organization (CDMO) that provides support services on a contractual basis to third-party customers in the OLED, pharma, biotech, catalysis and other industries. As of June 30, 2026, Adesis employed a team of 134 research scientists, chemists, engineers and laboratory technicians. Prior to our acquisition of Adesis, we utilized more than 50% of Adesis’ technology service and production output. We continue to utilize a significant portion of its technology research capacity for the benefit of our OLED technology development, and Adesis uses the remaining capacity to operate as a CDMO by providing contract research services for non-OLED applications to third-party customers in the above-mentioned industries. Contract research services revenue is earned by providing chemical materials synthesis research, development and commercialization for non-OLED applications on a contractual basis for those third-party customers.

In June 2020, we formed a wholly-owned subsidiary, OVJP Corporation (OVJP Corp), operating in California, in order to advance the commercialization of our proprietary Organic Vapor Jet Printing (OVJP) technology, which we now refer to as Universal Vapor Jet Printing (UVJP). In December 2024, we announced that the OVJP Corp facility in California would be closing and UVJP operations would be relocated to our newly formed Singapore subsidiary, Universal Vapor Jet Corporation Pte. Ltd. (UVJC), as well as continued operations in our Tech and Innovation Center in New Jersey. While we continue to focus on the long-term opportunity in the large-area display market for UVJP, the industry’s current focus is on the growing demand for IT capacity. Our UVJC subsidiary continues to assess additional market opportunities where this technology may be transformative.

In February 2021, we announced the establishment of a new manufacturing site in Shannon, Ireland and an agreement between UDC Ireland Limited and PPG for the production of our OLED materials. The Shannon manufacturing facility became operational in June 2022 and we purchased the site during September 2023. The Shannon manufacturing facility provides incremental manufacturing capacity to meet our expanding production needs, and allows for the geographical diversification of our manufacturing base for the world-wide distribution of our materials.

We also generate technology development and support revenue earned from development and technology evaluation agreements and commercialization assistance fees.

30

We anticipate fluctuations in our annual and quarterly results of operations due to uncertainty regarding, among other factors:

•
the timing, cost and volume of sales of our OLED materials;

•
the timing of our receipt of license fees and royalties, as well as fees for future technology development and evaluation;

•
the timing and magnitude of expenditures we may incur in connection with our ongoing research and development and patent-related activities; and

•
the timing and financial consequences of our formation of new business relationships and alliances.

RESULTS OF OPERATIONS

Comparison of the Three Months Ended June 30, 2026 and 2025

[Excerpt truncated for page length; source filing is linked above.]

## Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/1005284/000119312526059371/oled-20251231.htm
Complete FY 2025 MD&A: /company/OLED/mda/fy2025/

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary.
Confidence: high
Filing date: 2026-02-19
Report date: 2025-12-31

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the section entitled “Selected Financial Data” in this report and our Consolidated Financial Statements and related notes to this report. This discussion and analysis contains forward-looking statements based on our current expectations, assumptions, estimates and projections. These forward-looking statements involve risks and uncertainties. Our actual results could differ materially from those indicated in these forward-looking statements as a result of certain factors, as more fully discussed in Item 1A of this report, entitled “Risk Factors.”

OVERVIEW

We are a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display applications, such as mobile phones, televisions, monitors, wearables, tablets, portable media devices, notebook computers, personal computers, automotive applications and specialty lighting products. Since 1994, we have been engaged and expect to continue to be primarily engaged, in funding and performing research and development activities relating to OLED technologies and materials, and commercializing these technologies and materials. We derive our revenue primarily from the following:

•
sales of OLED materials for evaluation, development and commercial manufacturing;

•
intellectual property and technology licensing;

•
technology development and support, including third-party collaboration efforts and providing support to third parties for commercialization of their OLED products; and

•
contract research services in the areas of chemical materials synthesis research, development and commercialization for non-OLED applications.

Material sales relate to our sale of OLED materials for incorporation into our customers’ commercial OLED products or for their OLED development and evaluation activities. Material sales are generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties.

We receive license and royalty payments under certain commercial, development and technology evaluation agreements, some of which are non-refundable advances. These payments may include royalty and license fees made pursuant to license agreements and also license fees included as part of certain commercial supply agreements. These payments are included in the estimate of total contract consideration by customer and recognized as revenue over the contract term based on material units sold at the estimated per unit fee over the life of the contract.

On December 2, 2022, we entered into a commercial patent license agreement with Samsung Display Co., Ltd. (SDC), replacing a previous license agreement that had been in place since 2018. This agreement, which covers the manufacture and sale of specified OLED display materials, was effective as of January 1, 2023 and lasts through the end of 2027 with an additional two-year extension option for SDC. Under this agreement, we are being paid a license fee, which includes quarterly and annual payments over the agreement term. The agreement conveys to SDC the non-exclusive right to use certain of our intellectual property assets for a limited period of time that is less than the estimated life of the assets

At the same time that we entered into the current commercial license agreement with SDC, we also entered into a material purchase agreement with SDC, which lasts for the same term as the license agreement and is subject to the same extension option. This new material purchase agreement replaced a previous purchase agreement that had been in place since 2018. Under the material purchase agreement, SDC agrees to purchase from us a minimum amount of red and green phosphorescent emitter materials for use in the manufacture of licensed products. This minimum commitment is subject to SDC’s requirements for phosphorescent emitter materials and our ability to meet these requirements over the term of the supplemental agreement.

In 2015, we entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display). In 2021, we and LG Display entered into new agreements that extended the terms of these agreements at least through the end of 2025. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under their patent portfolio. The patent license calls for minimum annual license fees and additional incremental license fees based on LG Display’s volume of sale of licensed products. The OLED commercial supply agreement provides for the sale of dopant and host materials for use by LG Display.

31

In 2023, we entered into new long-term, multi-year agreements with BOE Technology Group Co., Ltd. (BOE). Under these agreements, we have granted BOE non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. We also supply phosphorescent OLED materials to BOE for use in its licensed products.

In 2019, we entered into an evaluation and commercial supply relationship with Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. (CSOT). In 2020, we entered into long-term, multi-year agreements with CSOT. Under these agreements, we have granted CSOT non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. We also supply phosphorescent OLED materials to CSOT for use in its licensed products.

In 2024, we entered into new long-term, multi-year agreements with Visionox Technology, Inc. (Visionox). Under these agreements, we have granted Visionox non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. Additionally, we supply phosphorescent OLED materials to Visionox for use in its licensed products.

In 2025, we entered into long-term, multi-year OLED patent license and material purchase agreements with Tianma Micro-electronics Co., Ltd. (Tianma). Under the agreements, we have granted Tianma non-exclusive license rights under various patents owned or controlled by us to manufacture and sell OLED display products. Additionally, we supply phosphorescent OLED materials to Tianma for use in its licensed products.

In 2016, we acquired Adesis, Inc. (Adesis) which has operations in New Castle and Wilmington, Delaware. Adesis is a contract development and manufacturing organization (CDMO) that provides support services on a contractual basis to third-party customers in the OLED, pharma, biotech, catalysis and other industries. As of December 31, 2025, Adesis employed a team of 137 research scientists, chemists, engineers and laboratory technicians. Prior to our acquisition of Adesis, we utilized more than 50% of Adesis’ technology service and production output. We continue to utilize a significant portion of its technology research capacity for the benefit of our OLED technology development, and Adesis uses the remaining capacity to operate as a CDMO by providing contract research services for non-OLED applications to third-party customers in the above-mentioned industries. Contract research services revenue is earned by providing chemical materials synthesis research, development and commercialization for non-OLED applications on a contractual basis for those third-party customers.

In June 2020, we formed a wholly-owned subsidiary, OVJP Corporation (OVJP Corp), operating in California, in order to advance the commercialization of our proprietary Organic Vapor Jet Printing (OVJP) technology, which we now refer to as Universal Vapor Jet Printing (UVJP). In December 2024, we announced that the OVJP Corp facility in California would be closing and UVJP operations would be relocated to our newly formed Singapore subsidiary, Universal Vapor Jet Corporation Pte. Ltd. (UVJC), as well as continued operations in our Tech and Innovation Center in New Jersey. While we continue to focus on the long-term opportunity in the large-area display market for UVJP, the industry’s current focus is on the growing demand for IT capacity. Our UVJC subsidiary continues to assess additional market opportunities where this technology may be transformative. As a result of the closure of the OVJP Corp location in California, we recorded $2.2 million and $8.9 million of restructuring costs for the years ended December 31, 2025 and 2024, respectively.

In February 2021, we announced the establishment of a new manufacturing site in Shannon, Ireland and an agreement between UDC Ireland Limited and PPG for the production of our OLED materials. The Shannon manufacturing facility became operational in June 2022 and we purchased the site during September 2023. The Shannon manufacturing facility provides incremental manufacturing capacity to meet our expanding production needs, and allows for the geographical diversification of our manufacturing base for the world-wide distribution of our materials

We also generate technology development and support revenue earned from development and technology evaluation agreements and commercialization assistance fees.

We anticipate fluctuations in our annual and quarterly results of operations due to uncertainty regarding, among other factors:

•
the timing, cost and volume of sales of our OLED materials;

•
the timing of our receipt of license fees and royalties, as well as fees for future technology development and evaluation;

•
the timing and magnitude of expenditures we may incur in connection with our ongoing research and development and patent-related activities; and

•
the timing and financial consequences of our formation of new business relationships and alliances.

32

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations is based on our Consolidated Financial Statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect our reported assets and liabilities, revenues and expenses, and other financial information. Actual results may differ significantly from our estimates under other assumptions and conditions.

We believe that our accounting policies related to revenue recognition and deferred revenue and income taxes, as described below, are our “critical accounting policies” as contemplated by the SEC. These policies, which have been reviewed with our Audit Committee, are discussed in greater detail below.

Revenue Recognition and Deferred Revenue

Material sales relate to the sale of our OLED materials for incorporation into our customers’ commercial OLED products or for their OLED development and evaluation activities. Revenue associated with material sales is generally recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties. Revenue may be recognized after control of the material passes in the event the transaction price includes variable consideration. For example, a customer may be provided an extended opportunity to stock materials prior to use in mass production and given a general right of return not conditioned on breaches of warranties associated with the specific product. In such circumstances, revenue will be recognized at the earlier of the expiration of the customer’s general right of return or once it becomes unlikely that the customer will exercise its right of return.

The vast majority of revenue attributed to material sales is determined through technol

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A: /company/OLED/mda/fy2025/
All MD&A years: /company/OLED/mda/


## MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

- [FY 2024 MD&A](/company/OLED/mda/fy2024/): filed 2025-02-20; accession 0000950170-25-024151 (https://www.sec.gov/Archives/edgar/data/1005284/000095017025024151/oled-20241231.htm)
- [FY 2023 MD&A](/company/OLED/mda/fy2023/): filed 2024-02-22; accession 0000950170-24-018765 (https://www.sec.gov/Archives/edgar/data/1005284/000095017024018765/oled-20231231.htm)
- [FY 2022 MD&A](/company/OLED/mda/fy2022/): filed 2023-02-23; accession 0000950170-23-004086 (https://www.sec.gov/Archives/edgar/data/1005284/000095017023004086/oled-20221231.htm)
- [FY 2021 MD&A](/company/OLED/mda/fy2021/): filed 2022-02-23; accession 0000950170-22-001770 (https://www.sec.gov/Archives/edgar/data/1005284/000095017022001770/oled-20211231.htm)




## Macro cross-references

Indicators mapped to this company's SIC classification (industry 3670 Electronic Components & Accessories) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

- [INDPRO](/indicator/INDPRO/): Industrial Production: Total Index
- [TCU](/indicator/TCU/): Capacity Utilization: Total Index
- [PPIACO](/indicator/PPIACO/): Producer Price Index by Commodity: All Commodities
- [GDPC1](/indicator/GDPC1/): Real Gross Domestic Product
- [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate
- [CES0500000003](/indicator/CES0500000003/): Average Hourly Earnings of All Employees, Total Private
- [PAYEMS](/indicator/PAYEMS/): All Employees, Total Nonfarm

Macro-to-micro threads including this sector: [Inflation (CPI / PCE / PPI)](/thread/inflation-cpi-pce-ppi/), [US labor market](/thread/us-labor-market/), [Growth & output](/thread/growth-output/), [Money & trade](/thread/money-trade/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/), [Industrial orders & inventories](/thread/industrial-orders/), [Trade & external](/thread/trade-external/).

All macro indicators: /indicators/


## For LLMs & downloads

Markdown twin: /company/OLED.md · JSON record: /company/OLED.json · verified financials: /company/OLED/financials.json / /company/OLED/financials.csv · machine TOC for the whole site: /llms.txt